Model-based drug development: strengths, weaknesses, opportunities, and threats for broad application of pharmacometrics in drug development. (Q50127370)
Jump to navigation
Jump to search
scientific article published in September 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Model-based drug development: strengths, weaknesses, opportunities, and threats for broad application of pharmacometrics in drug development. |
scientific article published in September 2010 |
Statements
1 reference
Model-based drug development: strengths, weaknesses, opportunities, and threats for broad application of pharmacometrics in drug development. (English)
1 reference
Jeffrey D Wetherington
1 reference
Marc Pfister
1 reference
Christopher Banfield
1 reference
Julie A Stone
1 reference
Rajesh Krishna
1 reference
Sandy Allerheiligen
1 reference
Dennis M Grasela
1 reference
1 September 2010
1 reference
50
1 reference
9 Suppl
1 reference
31S-46S
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference